CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin

BACKGROUND: The CBR3 V244M single nucleotide polymorphism has been linked to the risk of anthracycline-related cardiomyopathy in survivors of childhood cancer. There have been limited prospective studies examining the impact of CBR3 V244M on the risk for anthracycline-related cardiotoxicity in adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Jennifer K., Karthikeyan, Badri, Quiñones-Lombraña, Adolfo, Blair, Rachael Hageman, Early, Amy P., Levine, Ellis G., Sharma, Umesh C., Blanco, Javier G., O’Connor, Tracey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111996/
https://www.ncbi.nlm.nih.gov/pubmed/33975650
http://dx.doi.org/10.1186/s40959-021-00103-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111996/
https://www.ncbi.nlm.nih.gov/pubmed/33975650
http://dx.doi.org/10.1186/s40959-021-00103-0

Ejemplares similares